<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Anti-phospholipid syndrome (APS) is an autoimmune disease caused by the appearance of anti-PL antibodies and developed with vascular thromboembolism and miscarriages (reviewed in [
 <xref rid="B170-ijms-20-02167" ref-type="bibr" class="xref">170</xref>]). Anti-PL involve lupus anticoagulant (LA), anti-Î²2GPI antibodies and anti-cardiolipin (anti-CL). The mechanism linking the binding of anti-PL antibodies to endothelial cells with cell activation is still under investigation. A great variety of infections are accompanied by increases in anti-PL mostly in viral infections (Hepatitis C virus, Epstein-Barr virus, Varicella virus, human immunodeficiency virus) (reviewed in [
 <xref rid="B171-ijms-20-02167" ref-type="bibr" class="xref">171</xref>]).
</p>
